
doi: 10.1002/iub.93
pmid: 18506846
AbstractHypoxia‐inducible factor 1 (HIF‐1) is a transcriptional activator that mediates adaptive responses to hypoxia. HIF‐1 activity is increased in the majority of human cancers as a result of genetic alterations and intratumoral hypoxia. HIF‐1 activates the transcription of genes that increase O2 availability by stimulating angiogenesis or that reprogram cellular metabolism to adapt to reduced O2 availability. Proof of principle studies in mouse models suggests that inhibition of HIF‐1 activity may have therapeutic effects, especially in combination with other anticancer drugs. © 2008 IUBMB IUBMB Life, 60(9): 591–597, 2008
Oxygen, Proto-Oncogene Proteins c-myc, Glucose, Von Hippel-Lindau Tumor Suppressor Protein, Neoplasms, Animals, Homeostasis, Humans, Hypoxia-Inducible Factor 1, Energy Metabolism, Reactive Oxygen Species, Carcinoma, Renal Cell
Oxygen, Proto-Oncogene Proteins c-myc, Glucose, Von Hippel-Lindau Tumor Suppressor Protein, Neoplasms, Animals, Homeostasis, Humans, Hypoxia-Inducible Factor 1, Energy Metabolism, Reactive Oxygen Species, Carcinoma, Renal Cell
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 141 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
